Jinlong Wang, Guoxing Huang, Quan Qin, Nianhua Dan, Xinlou Li, Kai Sun, Yuan Yang, Meng Wang
{"title":"Performance study of ZnO-TPU/CS bilayer composite electrospinning scaffold in skin wound healing.","authors":"Jinlong Wang, Guoxing Huang, Quan Qin, Nianhua Dan, Xinlou Li, Kai Sun, Yuan Yang, Meng Wang","doi":"10.3389/fbioe.2025.1636932","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The high incidence of skin injuries and the limitations of conventional dressings highlight the need for advanced wound care materials. Electrospun nanofibrous scaffolds, with their extracellular matrix-like architecture, offer potential to enhance healing.</p><p><strong>Methods: </strong>A bilayer nanofibrous scaffold of thermoplastic polyurethane (TPU) and chitosan loaded with zinc oxide nanoparticles (ZnO) (TPU/CS@ZnO) was fabricated via electrospinning. The scaffold consisted of a hydrophobic TPU outer layer for waterproof protection and a hydrophilic TPU/CS@ZnO inner layer for bioactivity. Physicochemical properties were characterized by morphology, mechanical strength, and wettability. Cytocompatibility was evaluated in vitro, and wound healing efficacy was tested in vivo using a full-thickness skin defect model.</p><p><strong>Results: </strong>The scaffold displayed uniform fibres with a base-layer diameter of 231.81 ± 44.85 nm, tensile strength of 8.42 ± 0.58 MPa, and Young's modulus of 17.96 ± 0.78 MPa. Water contact angles confirmed hydrophilic and hydrophobic layer characteristics (52.68° ± 4.46° vs. 113.60° ± 2.85°). In vitro studies showed enhanced cell proliferation and adhesion, while in vivo experiments demonstrated over 90% wound closure at day 14, significantly faster than untreated groups. Histological analysis indicated contributions from cellular adhesion, angiogenesis, and immunomodulation.</p><p><strong>Discussion: </strong>The bilayer TPU/CS@ZnO scaffold integrates structural protection with biological activity, accelerating wound repair through multiple mechanisms. These findings support its potential as a multifunctional wound dressing, while further studies are needed to clarify molecular pathways and advance clinical application.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1636932"},"PeriodicalIF":4.8000,"publicationDate":"2025-09-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12484145/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1636932","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Introduction: The high incidence of skin injuries and the limitations of conventional dressings highlight the need for advanced wound care materials. Electrospun nanofibrous scaffolds, with their extracellular matrix-like architecture, offer potential to enhance healing.
Methods: A bilayer nanofibrous scaffold of thermoplastic polyurethane (TPU) and chitosan loaded with zinc oxide nanoparticles (ZnO) (TPU/CS@ZnO) was fabricated via electrospinning. The scaffold consisted of a hydrophobic TPU outer layer for waterproof protection and a hydrophilic TPU/CS@ZnO inner layer for bioactivity. Physicochemical properties were characterized by morphology, mechanical strength, and wettability. Cytocompatibility was evaluated in vitro, and wound healing efficacy was tested in vivo using a full-thickness skin defect model.
Results: The scaffold displayed uniform fibres with a base-layer diameter of 231.81 ± 44.85 nm, tensile strength of 8.42 ± 0.58 MPa, and Young's modulus of 17.96 ± 0.78 MPa. Water contact angles confirmed hydrophilic and hydrophobic layer characteristics (52.68° ± 4.46° vs. 113.60° ± 2.85°). In vitro studies showed enhanced cell proliferation and adhesion, while in vivo experiments demonstrated over 90% wound closure at day 14, significantly faster than untreated groups. Histological analysis indicated contributions from cellular adhesion, angiogenesis, and immunomodulation.
Discussion: The bilayer TPU/CS@ZnO scaffold integrates structural protection with biological activity, accelerating wound repair through multiple mechanisms. These findings support its potential as a multifunctional wound dressing, while further studies are needed to clarify molecular pathways and advance clinical application.
期刊介绍:
The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs.
In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.